MartaMargetaMDPhD

PubMed

• Severe Adult-Onset Non-Dystrophic Myotonia With Apnea and Laryngospasm Due to Digenic Inheritance ofandVariants: A Case Report.
  Madina Tugizova, Marta Margeta, Megan Richie, Douglas Pet, Laura Rosow
  Neurology. Genetics. 2025-02-01
• Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ...
  Michael W Lawlor, Benedikt Schoser, Marta Margeta, Caroline A Sewry, Karra A Jones
  Ebiomedicine. 2024-01-01
• 2 citations
  Where is the field of autophagy research heading?
  Hagai Abeliovich, Jayanta Debnath, Wen-Xing Ding, William T Jackson, Do-Hyung Kim
  Autophagy. 2023-04-01

Journal Articles

• LC3 and p62 as diagnostic markers of drug-induced autophagic vacuolar cardiomyopathy: A study of three cases.  
  Daniels B.H., McComb R.D., Mobley B.C., Gultekin S.H., Lee H.S., and Margeta M., Am. J. Surg. Pathol., 1/1/2013
• Rare somatic cells from human breast tissue exhibit extensive lineage plasticity.  
  Roy A., Gascard P., Dumont N., Zhao J., Pan D., Petrie S., Margeta M., and Tlsty T.D, Proc. Natl. Acad. Sci. U.S.A., 1/1/2013
• Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.  
  Hiniker A., Daniels B.H., LeeH.S., and Margeta, M., Acta Neuropathol. Commun., 1/1/2013
• Clinical utility of LC3 and p62 immunohistochemistry in diagnosis of drug-induced autophagic vacuolar myopathies: A casecontrol study.  
  Lee H.S., Daniels B.H., Salas E., Bollen A.W., Debnath J., and Margeta M, PloS ONE, 1/1/2012
• Molecular basis for vulnerability to mitochondrial and oxidative stress in a neuroendocrine CRI-G1 cell line.  
  Chandiramani N, Wang X, and Margeta M, PloS ONE, 1/1/2011
• Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I.  
  Margeta M., Connolly A.M., Widner T.L., Pestronk A., and Moore S.A., Muscle Nerve, 1/1/2009
• Dermatomyositis with inclusion body myositis pathology.  
  Layzer R., Lee H., Iverson D., and Margeta M., Muscle Nerve, 1/1/2009
•  
  Cheng Z., Tu C., Rodriguez L., Chen T.-H., DvorakM.M., MargetaM., Gassmann M., Bettler B., Shoback D. and Chang W, Endocrinology, 1/1/2007
•  
  Chang W., Tu C., Cheng Z., Rodriguez L., Chen T.-H., Gassmann M., Bettler B., MargetaM., Jan L.Y., and Shoback D., J. Biol.Chem., 1/1/2007
• Infant botulism, type F, presenting at 54 hours of life.  
  Keet C.A., Fox C.K., MargetaM., Marco E., Shane A.L., DeArmond S.J., Strober J.B., and Miller S.P., Pediatr. Neurol., 1/1/2005
•  
  Mitrovic I., Margeta-MitrovicM., Bader S., Stoffel M., Jan L. Y. and BasbaumA. I., Proc. Natl. Acad. Sci. U.S.A., 1/1/2003
• Assembly-dependent trafficking assays in the detection of receptor-receptor interactions.  
  Margeta-MitrovicM., Methods, 1/1/2002
• Ligand-induced signal transduction within heterodimeric GABAB receptor.  
  Margeta-MitrovicM., Jan Y. N. and Jan L. Y., Proc. Natl. Acad. Sci. U.S.A., 1/1/2001
• Function of GB1 and GB2 subunits in G protein coupling of GABAB receptors.  
  Margeta-MitrovicM., Jan Y. N. and Jan L. Y., Proc. Natl. Acad. Sci. U.S.A., 1/1/2001
• A trafficking checkpoint controls GABAB receptor heterodimerization.  
  Margeta-MitrovicM., Jan Y. N. and Jan L. Y., Neuron, 1/1/2000
• Immunohistochemical localization of GABAB receptors in the rat central nervous system.  
  Margeta-MitrovicM.#, Mitrovic I.#, Riley R.C.#, Jan L.Y. and Basbaum A.I. (#Equal contribution), J. Comp. Neurol., 1/1/1999
• Neurotensin and substance P inhibit low- and high-voltage activated Ca2+ channels in cultured newborn rat nucleus basalis neurons.  
  Margeta-MitrovicM., Grigg J.J., Koyano K., Nakajima Y. and Nakajima S., J. Neurophysiol., 1/1/1997
• Join now to see all

Books/Book Chapters

• Handbook of Cell Signaling. 
  Chapter: Functional role(s) of dimeric complexes formed from G-proteincoupled receptors. Chapter 32. 
  Margeta-Mitrovic, M. and Jan, L. Y.Editors: Bradshaw, R. A. and Dennis, E. A..Elsevier Academic Press2003

Abstracts/Posters

• A novel mitochondrial DNA mutation (m12293G>A) associated with rapidly progressive adult-onset scoliosis. (Poster)
  Hiniker A., Berven S., Adesina A., and Margeta M., J. Neuropathol. Exp. Neurol., 1/1/2013
• Neuronal activity regulates Nrf2 antioxidant pathway in perisynaptic astrocytes. (Platform Presentation)
  Habas A., Wang X., Hahn J., and Margeta M., J. Neuropathol. Exp. Neurol., 1/1/2013
• Polymyositis and inclusion body myositis in HIV-positive individuals: A study of 19 cases. (Platform Presentation)
  Hiniker A., Daniels B., and Margeta M., J. Neuropathol. Exp. Neurol., 1/1/2013
• Clinical utility of LC3 and p62 immunohistochemistry in diagnosing the spectrum of T-cell mediated inflammatory myopathies. (Platform Presentation)
  Hiniker A., Daniels B., Lee H., and Margeta M., J. Neuropathol. Exp. Neurol., 1/1/2012
• Clinical utility of LC3 and p62 immunohistochemistry in diagnosis of drug-induced autophagic vacuolar cardiomyopathy. (Platform Presentation)
  Daniels B., McComb R., Mobley B., Gultekin S., Lee H., and Margeta M., J. Neuropathol. Exp. Neurol., 1/1/2012
• Nrf2 signaling modulates neuronal NMDA receptor currents in a glia-dependent manner. (Platform Presentation)
  Hahn J., Wang X., and Margeta M., J. Neuropathol. Exp.Neurol., 1/1/2011
• Immunohistochemistry for LC3 as a diagnostic marker for drug-induced autophagic myopathy. (Platform Presentation)
  Lee H., Daniels B., Salas E., Bollen A., Debnath J., and Margeta M, J. Neuropathol. Exp. Neurol., 1/1/2011
• Nrf2 modulation of NMDA receptor currents in primary hippocampal cultures. (Poster)
  Hahn J., Wang X., and Margeta M, Program No. 345.6, 2010 Neuroscience Meeting Planner; Society for Neuroscience (Online), San Diego, CA, 1/1/2010
• Neuron-astrocyte interaction is required for induction of Nrf2 antioxidant pathway by neuronal activity. (Poster)
  Habas A., Hahn J., Chandiramani N., and Margeta M., Program No. 345.5, 2010 Neuroscience Meeting Planner; Society for Neuroscience (Online), San Diego, CA, 1/1/2010
• Regulation of Nrf2 antioxidant pathway by synaptic activity. (Poster)
  Habas A., Chandiramani N., and Margeta M., Program No. 324.5, 2009 Neuroscience Meeting Planner; Society for Neuroscience (Online), Chicago, IL, 1/1/2009
• Cardiac pathology in a case of limb-girdle muscular dystrophy type 2I (LGMD-2I). (Poster)
  Margeta, M., Winder T.L. and Moore S.A., FASEB J, 1/1/2008
• Intrathecal application of saporin conjugates leads to development of pituitary adenomas in rats. (Platform Presentation)
  MargetaM., Ohara P.T., Bollen A.W. and Jasmin L., J.Neuropathol. Exp. Neurol., 1/1/2004
• Contribution of GIRK2 channels to morphine and clonidine antinociception: a possible mediator of sex differences. (Poster)
  Mitrovic I., Yi E., Margeta-MitrovicM., Stoffel M. and Basbaum A.I., Soc. Neurosci. Abstr., 1/1/2000
• The function of the GIRK2 channels in morphine tolerance. (Poster)
  Mitrovic I., Margeta-MitrovicM., Stoffel M., Jan L.Y. and Basbaum A.I., Soc. Neurosci. Abstr., 1/1/1999
• Altered morphine analgesia in GIRK2 null mice. (Poster)
  Mitrovic I., Margeta-MitrovicM., StoffelM., Jan, L.Y. and Basbaum, A.I., Soc. Neurosci. Abstr., 1/1/1998
• Modulation of calcium currents by substance P and neurotensin in cultured rat nucleus basalis neurons. (Platfrom Presentation)
  Margeta-MitrovicM., Nakajima Y. and Nakajima S., Soc. Neurosci. Abstr., 1/1/1995
• Join now to see all

Lectures

• UCSF Neuroscience Breakfast. (Seminar) 
  1/1/2012
• UCSF Brain Biology and Mood Study Group. (Seminar) 
  1/1/2011
• UCSF Signaling Club. (Seminar) 
  1/1/2011
• UCSF Pathology and Lab Medicine Research Interest Group. (Seminar) 
  1/1/2011
• UCSF Neuropathology Group. (Seminar) 
  1/1/2010
• UCSF BMS Graduate Program Faculty Talks. (Seminar) 
  1/1/2009
• San Francisco VA Hospital, Neurology Research Unit. (Seminar) 
  1/1/2008
• University of California San Francisco. (Seminar) 
  1/1/2007
• University of California San Diego. (Seminar) 
  1/1/2006
• Oregon Health Sciences University. (Seminar) 
  1/1/2006
• UCSFMemory and Aging Center. (Seminar) 
  1/1/2004
• Molecular Pharmacology Gordon Research Conference. (Plenary Session) 
  1/1/2001
• University of Illinois at Chicago. (Seminar) 
  1/1/2000
• Join now to see all

Other

• Kir3.1 Molecular Page. 
  Margeta, M.
  http://www.signaling-gateway.org
  2001-2003 - 1/1/2004
• Modulation of neuronal calcium channels by neurotensin and substance P. (Ph.D. Dissertation) 
  Margeta-Mitrovic, M.
  1/1/1996
• Effects of splenectomy on murine immunological functions. (M.D. Dissertation) 
  Margeta, M.
  1/1/1991